Views & Analysis Towards Patient Centricity: LEO Pharma Industry plays a pivotal role in making sure patient needs are not overlooked by the wider healthcare community.
News Novartis ups 2019 guidance after strong Q2 Novartis has revised its guidance for 2019 upwards after a strong set of Q2 figures, with its psoriasis drug Cosentyx being the star performer.
News BMS will shed Otezla to push Celgene takeover through Bristol-Myers Squibb has opted to divest big-selling psoriasis drug Otezla to smooth the passage of its $74 billion takeover of Celgene through the financial regulatory seas.
Views & Analysis Patient Insights: Severe psoriasis & eczema Howard Chang has lived with severe psoriasis and atopic dermatitis for almost 40 years since childhood.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
